论文部分内容阅读
美多心安(Metoprolol)为一种交感神经β_1受体阻滞剂(心脏选择性),国外已在临床上应用于高血压及心绞痛的治疗,但对国内病人的疗效尚待评价。本文报告美多心安治疗高血压病57例的疗效,降压有效率为71.9％,显效率为43.9％。病人的头昏、头痛、心悸、眩晕、胸闷等症状也有明显的改善。适用于Ⅰ、Ⅱ期高血压病人。该药副作用较少,是一种有效的降压药。
Metoprolol is a sympathetic β-1 blocker (cardiac selectivity), which has been used clinically in the treatment of hypertension and angina pectoris. However, the curative effect on patients in China is yet to be evaluated. This article reports the treatment of 57 cases of Hypertension with Meaduoxinan, the effective rate of antihypertensive is 71.9% and the effective rate is 43.9%. Patients with dizziness, headache, palpitations, dizziness, chest tightness and other symptoms have also been significantly improved. For Ⅰ, Ⅱ hypertensive patients. The side effects of the drug less, is an effective antihypertensive drugs.